|
Sep 22, 2017
These stocks climbed despite a mixed market. Find out why.
|
|
Sep 22, 2017
Even though the market stayed close to unchanged, these stocks fell. Find out why.
|
|
Sep 22, 2017
The future of Intercept's liver disease drug hangs in the balance after an FDA warning letter.
|
|
Sep 22, 2017
They enjoy dominant positions in the healthcare and consumer products industries. But which is the better buy for investors today?
|
|
Sep 22, 2017
The number of tendered shares plunged again in September. What's next?
|
|
Sep 22, 2017
Optimism that it can develop CAR-T cancer drugs that are better than its competitors' is trumping news that the company is diluting investors by selling more shares.
|
|
Sep 22, 2017
The mineral producer is having a production problem at one of its mines.
|
|
Sep 22, 2017
A few innovative advances are all that stand between the camera tech specialist and much stronger growth.
|
|
Sep 22, 2017
The athletic footwear retail specialist delivered earnings at the high end of its latest guidance. Here's what investors need to know.
|
|
Sep 22, 2017
Concerns over valuation have investors worried.
|
|
